Published September 7, 2023 | Version v1
Journal article Open

Selection of the optimal extraction method for European Mistletoe

Description

Introduction. The therapeutic properties of European Mistletoe (Viscum album L.) have been known since ancient times. This plant contains various biologically active compounds that contribute to its diverse pharmacological effects. Extracts from European Mistletoe have been found to exhibit direct cytotoxic and immunomodulating properties, making them suitable candidates for antitumor agents. The presence of polyphenolic and other compounds that dilate blood vessels, lower blood pressure, and reduce triglyceride levels in serum suggests that other extraction preparations from European Mistletoe could be recommended as standalone agents for the prevention and treatment of hypertension, angina, and vascular atherosclerosis. Objective. The study aimed to select a rational method for obtaining alcohol extract from European Mistletoe for the further development of a preparation with anti-atherosclerotic properties. The research had two main objectives: the selection of an effective extraction method and the determination of optimal extraction conditions for maximum recovery of the targeted BAC. Materials and Methods. Fresh shoots with leaves of European Mistletoe were selected as the subject of the study. After comminution and determination of key technological properties, extraction was carried out using the maceration method and extraction under variable pressure in the laboratory extractor "Timatic Micro 0.5" from the Italian company "Technolab". Results and Discussion. Comparative experimental studies were conducted to determine the optimal extraction method and main technological parameters for the extraction of the raw material. It was established that extracts obtained by the extraction method under variable pressure exhibited better quality indicators. The optimal extraction parameters for European Mistletoe shoots and leaves were determined as follows: fineness – 5±2 mm, "raw material: extract" ratio (DER) – 1:10, pressure – 5 atm, compression time – 3 min, decompression time – 3 min, number of cycles – 20, total process time – 120 min. Conclusions. Based on the conducted research, the extraction method under variable pressure was selected as the optimal approach for obtaining extracts from European Mistletoe. The effective extraction conditions were experimentally determined. Qualitative and quantitative evaluation of the obtained extract was conducted, confirming the correctness of choosing the extraction method for Viscum album.

Keywords: European Mistletoe, cardiovascular diseases, extract, extraction under variable pressure, Timatic Micro extractor.

Files

sichkarFIN.pdf

Files (329.9 kB)

Name Size Download all
md5:d68f2aa3439ba0235cf776915fce7d86
329.9 kB Preview Download

Additional details

References

  • 1. Phytotherapy. Medicinal plants. Mistletoe. URL: http://ua.oovacia.com.ua/index.php/fitoterapiya/52-likarski-roslini/117-omela-tsilyushchi-vlastivosti-pokazannya-retsepti.
  • 2. Complete Atlas of Medicinal Plants / comp. I.S. Alekseev. Donetsk: Gloria Trade LLC. 2013. 400 p.
  • 3. Trutaev SI. Development of the composition and technologies of tincture on the basis of vegetative raw material for treatment of an atherosclerosis. Abstract of thesis for the Candidate of Pharmacy Degree in speciality 15.00.01. Kharkiv, 2010. 20 p.
  • 4. Committee on Herbal Medicinal Products (2012) Assessment report on Viscum album L., herba. Committee on Herbal Medicinal Product. London. URL: https://www.ema.europa.eu/en/ documents/herbal-report/final-assessment-report-viscum-album-l-herba_en.pdf
  • 5. Viscum album. URL: https://www.britannica.com/plant/mistletoe.
  • 6. Voloshyn OI., Bachuk-Ponych NV., Bobkovych KO. et al. Viscum album – promising medical herb with diverse mechanism of action, clinical and pathophysiological aspects of application in internal medicine and oncology (literature review). Phytotherapy. Journal. 2019. № 1. Р. 18-23. URL: http://nbuv.gov.ua/UJRN/Fch_2019_1_6
  • 7. Poruthukaren KJ., Palatty PL., Baliga MS. et al. Clinical evaluation of Viscum album mother tincture as an antihypertensive: a pilot study. J Evid Based Complementary Altern. Med. 2014. № 19(1). Р. 31-35. DOI: 10.1177/2156587213507726
  • 8. Kienly GS., Kiene H. Influence of Viscum album L. (European Mistletoe) Extracts on Qualiti life in cancer patients: A systemic Review of Controlled Clinical Studies. Integrative Cancer Ther. 2010. Vol. 9(2). P. 142-157.
  • 9. Voloshyn OI., Vasiuk VL, Voloshyna LO et al. Fundamentals of Phytotherapy and Homeopathy. 2nd edition. Chernivtsi: «Misto». 2017. P. 137-145.
  • 10. Vicas SI., Rugina D., Socaciu C. Antioxidant Activity of European Mistletoe (Viscum album). URL: https://www.researchgate.net/publication /221920678_Antioxidant-Activity_of_European_Mistletoe_Viscum_album#pf2.
  • 11. Melzer J., Iten F., Hostanska K. et al. Efficacy and Safety of Mistletoe Preparations for Patients with Cancer Disease. Forschende Komplementär medizin. 2009. Vol. 16. P. 217-226.
  • 12. Zupanets IA., Tattis A., Shebeko SK. et al. Atherosclerosis: therapeutic and preventive possibilities of herbal medicines. Clinical pharmacy. 2016. Vol. 20, № 3. P. 18-22. URL: http://nbuv.gov.ua/UJRN/KlPh_2016_20_3_6
  • 13. Tashchuk VK, Polyanska OS. Atherosclerosis is a problem of modern civilization. URL: https://www.bsmu. edu.ua/uk/news/digest/4838-ateroskleroz-tse-problema-suchasnoi-tsivilizatsii.
  • 14. Szurpnicka A., Kowalczuk A., Szterk A. Biological activity of mistletoe: in vitro and in vivo studies and mechanisms of action. Arch. Pharm. Res. 2020. № 43. P. 593-629.
  • 15. Kienle GS., Grugel R., Kiene H. Safety of higher dosages of Viscum album L. in animals and humans-systematic review of immune changes and safety parameters. Complement Altern Med. 2011. №11. Р. 72.
  • 16. State Register of Medicines of Ukraine. URL: http://www.drlz.com.ua.
  • 17. Compendium. Reference book of medicines. URL: https://compendium.com.ua/uk/
  • 18. The World Health Organization. URL: http://www.who.int.
  • 19. It became known what Ukrainians die from: in the first place are cardiovascular diseases, in the second – oncology. URL: https://ukranews.com/news/733617-v-2020-godu-ukraintsy-bolshe-vsego-umirali-ot-problem-s-serdtsem-i-sosudami-a-takzhe
  • 20. Cardiovascular diseases claim the lives of about 400,000 Ukrainians annually. URL: https://www.apteka.ua/article/427963.
  • 21. State Pharmacopoeia of Ukraine. SE "Ukrainian Scientific Pharmacopoeia Center for the Quality of Medicinal Products". 2nd edition. Kharkiv. State "Ukrainian Scientific Pharmacopoeia Center for the Quality of Medicinal Products". 2015. Vol. 1. 1128 p.
  • 22. Tertychko AV., Trutaev SI. Study of the technological parameters of the raw materials of white mistletoe for the production of tincture. Ensuring the health of the nation and the health of the individual as a priority function of the state: Materials of the International Scientific and Practical Conference. Odesa. January 22-23, 2021. Odesa. Public organization "Southern Foundation of Medicine". 2021. P. 25-28.
  • 23. Gladukh IeV., Ruban OA., Sayko ІV. et al. Industrial technology of drugs: a basic textbook for students of higher education (pharmaceutical faculties). Kharkiv: NPhU: Original, 2016. 632 p. URL: https://dspace.nuph.edu.ua/handle/123456789/23539?locale=en
  • 24. Gladukh IeV., Sayko ІV., Sichkar AA. et al. Theoretical foundations of pharmaceutical technology: manual. Kharkiv: NPhU, 2016. 203 p.
  • 25. Soldatov D., Stepanenko S., Sayko I. et al. Research of Vitis Vinifera Leaves Extraction Process on Timatic Laboratory Extractor. Scripta Scientifica Pharmaceutica. 2019. 6(1). P. 45-52. DOI: http://dx.doi.org/10.14748/ssp.v6i1.5654
  • 26. Timatic Micro. URL: http://www.timatic.it/index.php/en/products/extractors-of-active/ timatic-micro.